S&T BANK/PA - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 206 filers reported holding MYRIAD GENETICS INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
S&T BANK/PA ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q4 2021$413,000
-30.6%
14,967
-18.8%
0.06%
-34.8%
Q3 2021$595,000
-48.5%
18,423
-51.2%
0.09%
-48.6%
Q2 2021$1,155,000
-13.0%
37,762
-13.4%
0.18%
-17.1%
Q1 2021$1,327,000
-79.7%
43,591
-86.8%
0.22%
-81.6%
Q4 2020$6,547,000
+46.7%
331,098
-3.3%
1.18%
+15.3%
Q3 2020$4,463,000
+24.6%
342,259
+8.4%
1.02%
+25.0%
Q2 2020$3,582,000
-21.3%
315,835
-0.7%
0.82%
-34.9%
Q1 2020$4,552,000
-50.3%
318,127
-5.3%
1.25%
-33.1%
Q4 2019$9,150,000
-4.0%
335,991
+2.3%
1.88%
-9.0%
Q3 2019$9,533,000
+105.8%
328,343
+96.9%
2.06%
+103.1%
Q2 2019$4,633,000
-6.9%
166,772
+11.3%
1.02%
-9.4%
Q1 2019$4,974,000
+13.9%
149,798
-0.3%
1.12%
+10.6%
Q4 2018$4,367,000
-42.5%
150,219
-9.0%
1.01%
-28.6%
Q3 2018$7,594,000
-37.0%
165,071
-48.9%
1.42%
-37.9%
Q2 2018$12,062,000
+5.4%
322,780
-16.6%
2.28%
+12.0%
Q1 2018$11,439,000
-30.1%
387,084
-18.7%
2.04%
-26.5%
Q4 2017$16,354,000
-7.3%
476,156
-2.3%
2.77%
-12.0%
Q3 2017$17,637,000
+33.2%
487,501
-4.9%
3.15%
+30.8%
Q2 2017$13,245,000
+32.7%
512,581
-1.4%
2.41%
+27.0%
Q1 2017$9,980,000
+22.3%
519,807
+6.2%
1.90%
+44.8%
Q4 2016$8,159,000
-38.5%
489,410
-24.1%
1.31%
-40.6%
Q3 2016$13,270,000
+29.0%
644,837
+91.9%
2.20%
+31.0%
Q2 2016$10,283,000
-17.6%
336,048
+0.8%
1.68%
-19.0%
Q1 2016$12,472,000
-12.9%
333,216
+0.4%
2.08%
-6.5%
Q4 2015$14,324,000
-5.0%
331,885
-17.5%
2.22%
-4.3%
Q3 2015$15,076,000
+9.9%
402,258
-0.3%
2.32%
+15.7%
Q2 2015$13,718,000
-1.5%
403,609
+2.6%
2.01%
-3.8%
Q1 2015$13,928,000
+7.7%
393,446
+3.6%
2.08%
+11.0%
Q4 2014$12,934,000
-4.2%
379,724
+8.5%
1.88%
-6.9%
Q3 2014$13,500,000
-0.4%
350,002
+0.5%
2.02%
-1.2%
Q2 2014$13,559,000
-17.0%
348,386
-27.1%
2.04%
-12.2%
Q1 2014$16,333,000
+56.4%
477,707
-4.0%
2.32%
+56.6%
Q4 2013$10,442,000
+11.5%
497,703
+24.9%
1.48%
+1.9%
Q3 2013$9,367,000
-17.1%
398,578
-5.2%
1.46%
-26.4%
Q2 2013$11,302,000420,6011.98%
Other shareholders
MYRIAD GENETICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 6,459,139$278,776,0005.53%
Tieton Capital Management, LLC 119,290$5,149,0004.04%
RPg Family Wealth Advisory, LLC 97,202$4,195,238,0003.85%
RK Capital 384,900$16,612,0002.90%
Contrarius Investment Management Ltd 652,288$28,153,0002.65%
S&T BANK/PA 331,885$14,324,0002.22%
Euclidean Technologies Management, LLC 40,917$1,766,0001.90%
AIMZ Investment Advisors, LLC 45,635$1,970,0001.80%
Taylor Frigon Capital Management LLC 34,783$1,486,0001.67%
KILLEN GROUP INC 366,305$15,810,0001.63%
View complete list of MYRIAD GENETICS INC shareholders